WASHINGTON (Reuters) – U.S. drugs regulators gave the nod to Astellas Pharma Inc‘s pill for overactive bladder on Thursday, boosting the Japanese drugmaker’s foothold in the market for the condition.
The Food and Drug Administration approved the once-daily pill, mirabegron, for adults who cannot control their bladder muscles, following a positive recommendation from FDA advisers.
(Reporting by Anna Yukhananov; Editing by Gerald E. McCormick)
Related posts:
The US and UK Want Black Box Recorders in Cars to Spy on Citizens
Panetta: China, Japan Heading Towards War
Small Stem Cell Study Claims Early Success in Treating Eye Disease
Released Iranians to fly home tomorrow
New technology can detect as little as 0.1 percent GMO contamination in crops, food
Meet Contemporary Art's "Bad Girls Of 2012" (PHOTOS)
Views: 0